Global /Japan /Industrials /Specialty Business Services /2395
chevron_leftBack
Shin Nippon Biomedical Laboratories, Ltd. logo

Shin Nippon Biomedical Laboratories, Ltd.

2395
TSE: 2395 Delayed
1,432JPY 0.7%
8.94 USD
As of 10 June 2026, Shin Nippon Biomedical Laboratories, Ltd. has a market cap of $369.4M USD, ranking #17216 globally and #1277 in Japan. It ranks #3978 in the Industrials sector, and #415 in the Specialty Business Services industry.
Global Rank
17216
Country Rank
1277
Sector Rank
3978
Industry Rank
415
Key Stats
Market Cap
$369.4MUSD
59.2B JPY
Enterprise Value
$534.54MUSD
85.66B JPY
Revenue (TTM)
$195.77MUSD
31.37B JPY
EBITDA (TTM)
$32.99MUSD
5.29B JPY
Net Income (TTM)
$24.9MUSD
3.99B JPY
EBITDA Margin
17%
Profit Margin
13%
PE Ratio
14.8
Forward PE
12.8
PS Ratio
1.9
PB Ratio
1.1
EV/EBITDA
10.5
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
CEO
Ryoichi Nagata open_in_new
Employees
1,532
Founded
1957
Website
snbl.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.7% 0.1% -2.1% -11% -1% 1.9%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
2395
株式会社新日本科学
ISIN: JP3379950003
Shares Out.:
41.632M1 Shares Float: 19.83M2
TV:
SA:
YF:
GF:
BA:
MS:
1,432 JPY
OTC Markets
MIC: OTCM
SBLOF
株式会社新日本科学
ISIN: JP3379950003
Shares Out.:
41.632M1 Shares Float: 18.53M2
TV:
SA:
YF:
GF:
BA:
MS:
9.36 USD
Frankfurt Stock Exchange
MIC: XFRA
YB3
株式会社新日本科学
ISIN: JP3379950003
TV:
SA:
YF:
GF:
BA:
YB3
MS:
7.40 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.

Similar Companies

Industry: Specialty Business Services (Japan)
Name
Market Cap diff.
PE
9735
$14.53B
2.33T JPY
4K%
22.1
PAYP
$13.65B
4K%
17.5
4523
$8.1B
1.3T JPY
2K%
30.4
6532
$4.97B
795.87B JPY
1K%
21.0
2331
$3.65B
585.61B JPY
889%
17.4
4194
$1.87B
300.04B JPY
407%
17.3
Industry: Specialty Business Services (Global)
Name
Market Cap diff.
PE
SHOP
$158.14B
43K%
129.8
VSURE
$132.34B
114.8B EUR
36K%
-
CTAS
$69.6B
19K%
36.8
REL
$63.5B
47.6B GBP
17K%
23.9
PYPL
$45.83B
12K%
9.4
$41.8B
56.91B CAD
11K%
-
chevron_leftBack